Quince Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 14/08/2026 | Mar 2026Filed 11/05/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 14/08/2026 | Mar 2025Filed 11/05/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 11/08/2025 | Mar 2024Filed 13/05/2025 |
|---|---|---|---|---|---|---|---|---|
| −$75 | $36 | −$13 | −$16 | −$15 | −$5.5 | −$28 | −$11 | |
| −$12.31 | $2.88 | −$0.25 | −$68.75 | −$3.42 | −$0.13 | −$0.64 | −$0.26 | |
| 6.1 | 9.2 | 54 | — | 4.4 | 43 | 43 | 43 |
Trend